Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 201.52M | 187.30M | 29.27M | 36.40M | 48.11M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.89M | 991.00K | 1.79M | 3.49M | 1.94M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 203.41M | 188.29M | 31.06M | 39.89M | 50.06M |
|
|
|||||
| Total Current Assets | 203.41M | 188.29M | 31.06M | 39.89M | 50.06M |
| Net Property, Plant & Equipment | 974.00K | 34.00K | 49.00K | 67.00K | 79.00K |
| Long-term Investments | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M |
| Goodwill | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M |
| Total Other Intangibles | 750.00K | 809.00K | 696.00K | 751.00K | 807.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 253.00K | 268.00K | 265.00K | 49.00K | 65.00K |
| Total Assets | 206.42M | 190.44M | 33.11M | 41.79M | 52.04M |
|
|
|||||
| Total Accounts Payable | 1.60M | 606.00K | 833.00K | 867.00K | 1.94M |
| Total Accrued Expenses | 8.64M | 4.81M | 5.37M | 2.89M | 5.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.74M | 7.49M | 5.63M | 3.77M | 1.26M |
| Total Finance Division Other Current Liabilities | 1.41M | 184.75M | -- | 1.56M | 1.44M |
| Total Other Current Liabilities | 1.41M | 184.75M | -- | 1.56M | 1.44M |
| Total Current Liabilities | 19.39M | 197.66M | 11.83M | 9.08M | 9.73M |
|
|
|||||
| Total Current Liabilities | 19.39M | 197.66M | 11.83M | 9.08M | 9.73M |
| Long-Term Debt | 5.60M | 7.46M | 9.32M | 11.19M | 8.67M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 712.00K | -- | -- | 5.00K | 21.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | 1.27M | -- | -- |
| Total Liabilities | 25.69M | 205.12M | 22.43M | 20.27M | 18.43M |
|
|
|||||
| Common Stock & APIC | 538.17M | 330.58M | 281.07M | 281.73M | 279.17M |
| Retained Earnings | -357.27M | -345.16M | -270.39M | -260.23M | -245.56M |
| Treasury Stock & Other | -166.00K | -88.00K | 2.00K | 10.00K | 9.00K |
| Total Common Equity | 180.73M | -14.68M | 10.68M | 21.52M | 33.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 180.73M | -14.68M | 10.68M | 21.52M | 33.62M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 180.73M | -14.68M | 10.68M | 21.52M | 33.62M |
|
|
|||||